OA-05 Efficacy of Forimtamig, a GPRC5DxCD3 Bispecific Antibody, in Patients with Relapsed/refractory Multiple Myeloma (RRMM): Analysis of Patient and Disease-Related Factors Associated with ResponsesSimon Harrison,Caroline Hasselbalch Riley,Salomon Manier,Sung-Soo Yoon,Antonio Pinto,Titouan Cazaubiel,Anna Guidetti,Rakesh Popat,Cyrille Touzeau,Enrique Ocio,Fritz Offner,Paula Rodriguez-Otero,Ilaria Rizzello,Maria-Victoria Mateos,Ann-Marie Broeske,Iryna Dekhtiarenko,Natalie Dimier,Jan Eckmann,Hans-Joachin Helms,Wolfgang Jacob,Meike Schneider,Nassim Sleiman,Martin Weisser,Carmelo Carlo-StellaClinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia（2023）引用 0|浏览61暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
